Your Search Returned 3 tagged news reports
January 29, 2013 Dalton Pharma Services, a leading provider of drug discovery, development and manufacturing services to pharmaceutical and biotechnology companies, today announced that the company has begun the first stage of its strategic
Tags:
Dalton's API manufacturing and aseptic fill/finish services under cGMP. Dalton president and CEO Peter Pekos said that having Oncovir on the company's strategic relationships list with innovative pharmaceutical clients is an important milestone for
Tags:
Dalton supplies chemistry, analytical and formulation development services to the biotechnology and pharmaceutical industries in the areas of chemistry, medicinal chemistry and fine chemical manufacture. The company provides cGMP manufacturing of
Tags: